LINC00910 and breast cancer: To test whether a decrease in enhancer activating H3K36me3 mark impacts gene transcription, we first assessed gene expression of PITPNC1 and LINC00910 following 9-day treatment of MCF10CA1a breast cancer cells with 7 μM PTS.